Literature DB >> 17050787

Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.

Dixan A Benitez1, Eulalia Pozo-Guisado, Alberto Alvarez-Barrientos, Pedro M Fernandez-Salguero, Enrique A Castellón.   

Abstract

Resveratrol is a polyphenol found at high concentrations in grapes and red wine with reported anticarcinogenic effects. We studied the molecular mechanism of resveratrol-induced apoptosis and proliferation arrest in prostate derived cells PZ-HPV-7 (nontumorigenic line), LNCaP (androgen-sensitive cancer line), and PC-3 (androgen-insensitive cancer line). Apoptosis and cell cycle distribution were evaluated by flow cytometry and proliferation by MTT assay and direct cell counting. Caspases, bax, bcl-2, cyclins, Cdks, p53, p21, and p27 were measured by Western blot and kinase activities of cyclin/Cdk complexes by immunoprecipitation followed by kinase assays with appropriate substrates. Resveratrol induced a decrease in proliferation rates and an increase in apoptosis in cancer cell lines in a dose- and time-dependent manner. These effects were coincident with cell accumulation at the G0/G1 phase. In LNCaP and PC-3, the apoptosis induced by resveratrol was mediated by activation of caspases 9 and 3 and a change in the ratio of bax/bcl-2. Expressions of cyclin D1, E, and Cdk4 as well as cyclin D1/Cdk4 kinase activity were reduced by resveratrol only in LNCaP cells. In contrast, cyclin B and Cdk1 expression and cyclin B/Cdk1 kinase activity were decreased in both cell lines in the presence of resveratrol. However, modulator proteins p53, p21, and p27 were increased by resveratrol only in LNCaP cells. These effects probably result in the observed proliferation arrest and disruption of cell cycle control. In addition, the specific differences found between LNCaP and PC-3 suggest that resveratrol acts through different mechanisms upon the androgen or estrogen receptor cell status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050787     DOI: 10.2164/jandrol.106.000968

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  59 in total

Review 1.  Cell cycle control as a basis for cancer chemoprevention through dietary agents.

Authors:  Syed Musthapa Meeran; Santosh Kumar Katiyar
Journal:  Front Biosci       Date:  2008-01-01

2.  Lentivirus-mediated Sirt1 shRNA and resveratrol independently induce porcine preadipocyte apoptosis by canonical apoptotic pathway.

Authors:  Wei-Jun Pang; Yan Xiong; Zhao Zhang; Ning Wei; Ni Chen; Gong-She Yang
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

3.  Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.

Authors:  Tze-chen Hsieh; Ching-Jen Yang; Chia-Yi Lin; Yong-Syu Lee; Joseph M Wu
Journal:  Carcinogenesis       Date:  2012-01-19       Impact factor: 4.944

Review 4.  Recent advances in the regulation of cholangiocarcinoma growth.

Authors:  Heather Francis; Gianfranco Alpini; Sharon DeMorrow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

5.  Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway.

Authors:  Senthil Selvaraj; Yuyang Sun; Pramod Sukumaran; Brij B Singh
Journal:  Mol Carcinog       Date:  2015-04-27       Impact factor: 4.784

6.  Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells.

Authors:  Md Asaduzzaman Khan; Han-Chun Chen; Xin-Xing Wan; Mousumi Tania; Ai-Hua Xu; Fang-Zhi Chen; Dian-Zheng Zhang
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

Review 7.  Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.

Authors:  Mohammad Athar; Jung Ho Back; Levy Kopelovich; David R Bickers; Arianna L Kim
Journal:  Arch Biochem Biophys       Date:  2009-06-15       Impact factor: 4.013

8.  Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.

Authors:  Guiming Li; Paul Rivas; Roble Bedolla; Dinesh Thapa; Robert L Reddick; Rita Ghosh; Addanki P Kumar
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

Review 9.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 10.  Apoptosis by dietary agents for prevention and treatment of prostate cancer.

Authors:  Naghma Khan; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.